Skip to content

SuperNO2VA Et Versus Oxygen Face Mask During Deep Sedation

Comparison of Hypoxemia During Deep Sedation Procedures Between Oxygen Face Mask and the SuperNO2VA Et: a Randomized Controlled Trial. iOXIGENATe Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05175573
Acronym
iOXYGENATE
Enrollment
110
Registered
2022-01-04
Start date
2022-06-07
Completion date
2022-11-01
Last updated
2022-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxemia

Keywords

oxygenation, hypoxemia, deep sedation, end-tidal CO2, continuous positive airway pressure

Brief summary

The primary objective of the study is to prospectively and randomly compare the incidence, duration, and severity of oxygen desaturation between a nasal mask with nasal positive airway pressure (PAP) versus oxygen therapy with a facemask during procedural deep sedation in patients considered high risk for hypoxia (ie: BMI ≥30 kg/m2 or documented Obstructive Sleep Apnea.

Interventions

DEVICESuperNO2VA Et Nasal Positive Pressure Mask

Nasal mask with capnography providing continuous positive airway pressure at 10LPM

DEVICESupplemental Oxygen Face Mask

Face mask with capnography providing oxygenation at 10 LPM

Sponsors

M.D. Anderson Cancer Center
CollaboratorOTHER
Vyaire Medical
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 18 years of age or older 2. Patients undergoing procedural deep sedation 3. American Society of Anesthesiology (ASA) Physical Status I-III 4. BMI ≥30 kg/m2 or documented Obstructive Sleep Apnea 5. Has provided written informed consent 6. Difficult airway

Exclusion criteria

1. Acute exacerbation of respiratory disorders, including COPD and asthma 2. Emergent procedures 3. Pregnancy 4. Previous enrollment in this study 5. Inability to provide informed consent 6. History of allergic reaction to Propofol 7. Tracheostomy 8.

Design outcomes

Primary

MeasureTime frameDescription
HypoxemiaOxygen saturation below 90% for >15 seconds during procedureCompare the percentage of time spent with oxygen saturation below 90%.

Secondary

MeasureTime frameDescription
Hypoxemic EpisodesOxygen saturation below 90% for >15 seconds during procedureCompare incidence, duration, and severity of oxygen desaturation (oxygen saturation below 90% for ≥15 seconds).
SedationTotal duration of procedureCompare the amount of propofol administered during induction and total dose administered for procedure.
Procedural InterruptionsTotal duration of procedureCompare the incidence and duration of procedural interruptions (ie: number of times and length of time the surgery has to be stopped due to light sedation).
Airway maneuversTotal duration of procedureCompare the incidence, duration, and reason for airway maneuvers.
Procedure DurationTotal duration of procedureCompare the length of time for the procedure (ie: length of time from procedure start to procedure end).
Oxygen desaturationOxygen saturation below 90% for >15 seconds during procedureCompare area under the curve of oxygen desaturation (AUCDesat), a metric which combines incidence, duration, and severity into a single measurement.
Patient SatisfactionTotal duration of procedure and post procedure in PACU (scale: 0 to 10; 0 - poor, 10 - excellent)Compare patient satisfaction scores (visual analog scale (VAS)) immediately after procedure 1. Overall experience 2. Quality of sedation
Patient ToleranceTotal duration of procedure and post procedure in PACU (scale: None, Mild, Moderate, Severe; multiple choice: Yes or No))Compare patient tolerance to SuperNO2VA Et compared to control (ie: nasal cannula at 10LPM) immediately after procedure 1. Pain experienced during procedure 2. Pain after the procedure 3. Nausea after awakening 4. Vomiting after awakening 5. Dizziness after awakening 6. Recollection of scope insertion 7. Recollection of scope removal 8. Awake during the procedure 9. Could drive at discharge if permitted k. Would work at discharge if permitted
Surgeon SatisfactionTotal duration of procedureCompare surgeon satisfaction scores for 1. Overall experience 2. Rating of sedation 3. Difficulty of patient to sedate 4. Quality of the procedure
Anesthesiologist SatisfactionTotal duration of procedureCompare anesthesiologists satisfaction scores 1. Overall experience 2. Rating of sedation 3. Difficulty of patient to sedate
Cardiac ComplicationsTotal duration of procedure and post procedure in PACUCompare the incidence of cardiac complications
RecoveryTotal duration of post procedure in PACUCompare recovery times 1. Ready to discharge 2. Actual discharge

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026